This site is intended for US Healthcare Professionals only. To report an adverse reaction or product complaint, call 1-888-BLUPRNT, option 2, or visit or contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Search Medical Information

Clinical trials

Explore clinical trials in the Blueprint Medicines pipeline

  • Clinical Trial Name
  • Title
  • Status
  • Phase
  • Study Number
  • Related Resources
  • Clinical Trial Name
  • Title

  • Status

  • Phase

  • Study Number NCT06931405
  • Related Resources
  • Clinical Trial Name
  • Title
  • Status
  • Phase
  • Study Number
  • Related Resources
  • Clinical Trial Name A Multicenter screening study to characterize the prevalence of the KIT D816V mutation in patients with suspected clonal mast cell disease
  • Title

    A Multicenter screening study to characterize the prevalence of the KIT D816V mutation in patients with suspected clonal mast cell disease

  • Status

  • Phase

    Screening Study

  • Study Number NCT07143669
  • Related Resources
  • Clinical Trial Name PANORAMA
  • Title

  • Status

    Recruiting

  • Phase

    Phase 4

  • Study Number NCT07264959
  • Related Resources

Contact Blueprint Medicines

Submit a Medical Inquiry Request information about our products.

Contact a Medical Science LiaisonOur representatives are available to help you with your medical inquiries.

Blueprint Medicines is a pharmaceutical company focusing on the research, development, and commercialization of products in oncology, hematology, and rare diseases. This website is for US healthcare professionals for educational purposes only. Scientific information and data may include investigational use(s) of compounds for which efficacy and safety have not been established. Blueprint Medicines does not promote or endorse the use of its products in a manner not consistent with the approved label.